Insiders · Profile

Carmine Bryce D.

EVP and Pres, Lilly Bio-Meds at Lilly (Eli). Filing since 16 Aug 2010. CIK 0001430788

Company
Date
Role
Action
Shares
Amount
Of holding
12 Dec 2011
EVP and Pres, Lilly Bio-Meds
Sold, plan not stated
5,787
$226.27K
10.1%
11 Nov 2011
EVP and Pres, Lilly Bio-Meds
Sold, plan not stated
5,700
$214.04K
9.1%
11 Oct 2011
EVP and Pres, Lilly Bio-Meds
Sold, plan not stated
5,700
$217.17K
8.3%
12 Sep 2011
EVP and Pres, Lilly Bio-Meds
Sold, plan not stated
5,700
$204.69K
7.7%
11 Aug 2011
EVP and Pres, Lilly Bio-Meds
Sold, plan not stated
5,700
$193.46K
7.1%
11 Jul 2011
EVP and Pres, Lilly Bio-Meds
Sold, plan not stated
5,700
$213.12K
6.7%
13 Jun 2011
EVP and Pres, Lilly Bio-Meds
Sold, plan not stated
5,700
$212.33K
6.2%
11 May 2011
EVP and Pres, Lilly Bio-Meds
Sold, plan not stated
5,700
$217.80K
5.8%
11 Apr 2011
EVP and Pres, Lilly Bio-Meds
Sold, plan not stated
5,700
$203.83K
5.5%
16 Feb 2011
EVP and Pres, Lilly Bio-Meds
Sold, plan not stated
3,100
$106.92K
2.9%
14 Jan 2011
EVP and Pres, Lilly Bio-Meds
Sold, plan not stated
3,100
$108.10K
5.2%
16 Dec 2010
EVP and Pres, Lilly Bio-Meds
Sold, plan not stated
3,100
$108.81K
4.9%
16 Nov 2010
EVP and Pres, Lilly Bio-Meds
Sold, plan not stated
3,100
$106.73K
4.7%
15 Oct 2010
EVP and Pres, Lilly Bio-Meds
Sold, plan not stated
3,100
$116.72K
4.5%
16 Sep 2010
EVP and Pres, Lilly Bio-Meds
Sold, plan not stated
3,100
$110.21K
4.3%
16 Aug 2010
EVP and Pres, Lilly Bio-Meds
Sold, plan not stated
3,100
$109.52K
4.1%
16 decisions on file.